Effects of Spesolimab on Hidradenitis Suppurativa Lesions Leads to Additional Research
In a Maui Derm NP+PA Summer poster presentation, investigators revealed that treatment with spesolimab resulted in a reduction of lesions.
SDPA Annual Summer Dermatology Conference Recap: Day 2
Catch up on coverage from the second day of the 2023 SDPA Annual Summer Dermatology Conference.
Dupilumab Efficacious in Urticaria Symptom, Quality of Life Improvement
Over 24 weeks, dupilumab demonstrated efficacy in patients with chronic spontaneous urticaria.
Renata Block, MMS, PA-C, Discusses the Role of the Dermatology PA Foundation in Supporting Physician Assistants
Renata Block, MMS, PA-C, talks about the role of physician assistants in dermatology and related organizations in supporting PAs.
Tapinarof Demonstrates Efficacy in Patient With Nonulcerated Necrobiosis Lipoidica
In the case of one patient, researchers found that topical tapinarof cream demonstrated therapeutic efficacy in nonulcerated necrobiosis lipoidica.
John Barbieri, MD, MBA, FAAD: Aligning Treatments With Patients' Experiences
John Barbieri, MD, MBA, FAAD, discusses his SDPA Annual Summer Dermatology Conference sessions, "Foundational Tools for Acne and Rosacea Management," and "Neutraceuticals and Cosmeceuticals: Which to Choose?"
Skin Cancer in the Realm of Inflammatory Dermatoses
Darrell Rigel, MD, discusses his SDPA Annual Summer Dermatology Conference, "Inflammatory Dermatoses: A Case-Based Review," particularly highlighting the relationship between skin cancer and the inflammatory disease realm.
Rising Antifungal Resistance Poses a Threat to Onychomycosis Treatment
A poster presented at the 2023 SDPA Annual Summer Dermatology Conference analyzed the growing threat of antifungal resistance, particularly with the treatment of onychomycosis in mind.
Reviewing Considerations for Pigmentary Disorders With Nicole Gunasekera, MD, MBA
Nicole Gunasekera, MD, MBA, presented a session on disorders of pigmentation at the 2023 SDPA Annual Summer Dermatology Conference.
Survey Results Show Moderate to Severe Psoriasis Increases Anxiety and Depression Levels
Researchers evaluated factors affecting quality of life and what to consider when determining a patient’s psoriasis treatment plan.
SDPA Annual Summer Dermatology Conference Recap: Day 1
Catch up on coverage from the first day of the 2023 SDPA Annual Summer Dermatology Conference.
Sights and Sounds of the SDPA Annual Summer Dermatology Conference: Day 1
Catch up on visual highlights and views from the first day of the SDPA Annual Summer Dermatology Conference in Boston, MA.
New and Promising Drugs in Inflammatory Dermatoses
Mark Lebwohl, MD, discusses his SDPA Annual Summer Dermatology Conference session, "Inflammatory Dermatoses: A Case-Based Review."
Tazarotene Led to Hyperpigmentation Improvement in Black Patients With Acne
A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed improvements to hyperpigmentation in a cohort of Black patients with moderate-to-severe acne.
Emphasizing Culturally Competent Care in Patients With Skin of Color
Omar Noor, MD, FAAD, discusses cultural competency in caring for patients with skin of color in dermatology.
Brodalumab Demonstrates Quality of Life, Mental Health Improvement in Patients Regardless of Prior Biologic Use
A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed statistically significant improvements among patients with psoriasis receiving brodalumab treatment.
Discussing Clinical Pearls in Dermatology With Omar Noor, MD, FAAD
Omar Noor, MD, FAAD, discusses his SDPA session, "Clinical Pearls for Pediatric and Adult Dermatology."
Plan Your Trip: What to do While Visiting Boston
When sessions, late-breaking research, and more conclude, there is no shortage of things to do in historic Boston.
POLL: What Topic Are You Most Looking Forward to at SDPA Summer 2023?
Click here to answer today's poll.
Previewing the SDPA Annual Summer Dermatology Conference: What to Expect
The conference aimed at providing dermatology physician assistants with the latest in the field begins tomorrow in Boston, Massachusetts.
.jpeg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Survey Results Show Moderate to Severe Psoriasis Increases Anxiety and Depression Levels")
